Cytoreductive Nephrectomy, Immunotherapy-Based Systemic Therapy Induce Benefit in mRCC
December 3rd 2020A pooled analysis compared survival among patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomy and either targeted therapy or immunotherapy regimens utilizing checkpoint inhibitors.